The SEC charged Thomas M. Henderson and his company with misusing funds raised from investors to benefit Henderson's business ventures.

Global pharmaceutical company Allergan, Inc. agreed to pay a $15 million penalty to settle SEC charges alleging that the company violated merger and acquisition tender offer disclosure requirements.

CFTC Commissioner J. Christopher Giancarlo set forth his regulatory priorities for the Commission. Outgoing CFTC Chair Timothy Massad listed regulatory accomplishments during his tenure and urged future regulators not to "dismantle the framework."

Global medical device manufacturer Zimmer Biomet Holdings, Inc. settled criminal and civil charges brought by the DOJ and SEC after the company was found to have violated a 2012 agreement settling previous Foreign Corrupt Practices Act allegations.

President Obama renominated Dr. Christopher James Brummer and Brian D. Quintenz to fill two CFTC commissioner vacancies.